Newsletter sign up


ADC University Our services

ADC Review
is made possible by:



Copyright 2017
Terms & Conditions


PEER-REVIEWED ARTICLES

Antibody Drug Conjugates Summit

The Vonlanthen Group is pleased to invite you to the Antibody Drug Conjugates Summit scheduled to take place on February 25-26, 2016 in Vienna, Austria.

This innovative B2B event will enable the participants to learn about protein modeling development and engineering advances, preclinical and clinical improvements, current ADC linker chemistry- better linker design for future generations, improving preclinical and clinical translation and creating strong and scalable processes.

Key Practical Learning Points of the Summit:

  • Increase benefits of ADC- dial in potency, target stratified patient populations and optimize dosing regimens
  • Ensure product and process robustness
  • Make more evidence-based decisions
  • Explore alternative opportunities for ADCs by reviewing the potential of using ADCs outside oncology
  • Learn about advances in Protein Modeling and Engineering Breakthroughs
  • How to screen for optimal site of conjugation, select better quality targets and explore new payload mechanisms of action?
  • Linker Design Decisions, Novel Payloads and Linker Technology, Next-Generation Chemistry for Improved Conjugation and Linker Stability
  • Characterization of ADCs, Preclinical and Clinical Advances, Translational Considerations
  • Engineering ADCs for Developability, Enhanced Specificity and Binding, and Reduced Toxicity

Who Should Attend:
CEOs, Directors, Heads & Managers Of Leading Application Creators & Suppliers Including:

  • Toxicology
  • Biologics
  • Molecular Biology
  • Chief Technology Officer; Chief Development Officer; Chief Scientific Officer; Senior Research Officer
  • Biotherapeutics; Molecular Medicine; Data analysis; Analytical & Formulation
  • Oncology Drug Development; Oncology Molecules
  • Medical information
  • Bioanalytical
  • Discovery Chemistry; Research & Development; Antibody Discovery
  • Protein Engineering; Process Sciences
  • Biopharmaceutical Development; Development Analytics and New Technologies:
  • Clinical Assay; Biologics Discovery and Design

It is also designed for professionals who work for the Industry of:

  • Pharmaceuticals,
  • Biologics,
  • Medicine;
  • Clinical Research Organizations;
  • Academic Research Centers;
  • Regulatory Agencies

 


Skip to toolbar